| Embryo | Cells | Quality | Status |
|---|---|---|---|
| 1 (leader) | 8-cell | 16/20 | Transferred |
| 2 | 3-cell | 15/20 | Transferred |
| 3 | 3-cell | 14/20 | Transferred |
| 4 | 3-cell | — | Kept in culture |
| 5 | 2-cell | — | Kept in culture |
| 6 | Undivided | — | Likely arrested |
| Stage | Count |
|---|---|
| Eggs retrieved | 7 |
| Fertilized (IVF) | 6 |
| Developing at Day 2 | 4 |
| Transferred (Day 3) | 3 |
| Remaining in culture | 3 |
| Reached blastocyst | 0 |
| Banked / frozen | 0 |
| Implanted | 0 |
| Date | Event |
|---|---|
| Feb 8–12 | Letrozole priming (CD3–7) |
| Feb 26–Mar 3 | Estradiol suppression (CD21–CD1) |
| Mar 4 | CD1 — period arrives |
| Mar 5 | Stimulation starts (Clomid + Puregon) |
| Mar 9 | Monitoring #1 — 6-8 follicles ~7.5mm; dose adjusted to 200 IU |
| Mar 13 | Monitoring #2 — lead 13mm (R), cohort 7-8mm (L); Orgalutran added |
| Mar 18 | Ovidrel trigger shot (11:30pm); Indomethacin started |
| Mar 20 | Egg retrieval — 7 eggs |
| Mar 21 | Fertilization report — 6/7 fertilized |
| Mar 22 | Day 2 — 4 of 6 still developing |
| Mar 23 | Day 3 fresh transfer — 3 embryos (8-cell leader + two 3-cells) |
| ~Mar 27 | Remaining 3 embryos failed to reach blastocyst — none frozen |
| Apr 4 | Period arrived — transfer unsuccessful. Beta drawn at LifeLabs. |
| Apr 6 | Clinic results call (expected) |
| Decision | Status | Notes |
|---|---|---|
| Self-pay vs. waitlist | Resolved | Proceeded self-pay; BC public waitlist remains open (est. 2028) |
| Protocol type | Resolved | Minimal stim (Clomid + Puregon + Orgalutran) |
| Fresh vs. freeze-all | Resolved | Fresh transfer on Day 3; lining was receptive. No PGT-A this cycle. |
| Number transferred | Resolved | 3 embryos — the leader + two lagging 3-cells, per Dr. Cheung's recommendation |
| Next cycle approach | Active | To discuss Apr 6: back-to-back vs. paced cycles, FET vs. fresh, protocol adjustments |
| Future cycle location | Open | Cross-border options explored: Budapest monitoring + Czech/Slovakia (LilyMed–Repromeda, Istenhegyi–GYNCARE). Full clinic research → |